While we have had a small team for several years now, 2012 was the first year that Friends of Katelyn decided to focus on fundraising in a big way. We have a great group of people that put a lot into the events we organize throughout the year. You can check out more about who we are and why we do it on our About page.

  • Currently Team “Yes! I am a Katelyn Friend!” has raised over $90,000!!

Here are our stats from past years:

  • 2013 LLS Team “Yes! I am a Katelyn Friend!”
    • Goal- $25,000
    • Total- $26,628
    • #2 team for the Chicago Light the Night Walk
    • Top 5 team for the entire state of Illinois
    • Events organized-
      • 2nd annual Katelyn M Joyce Memorial Golf Outing
      • Zombie Prom
      • Wine Tasting Event
      • Online, individual fundraising
  • 2012 LLS Team “Yes! I am a Katelyn Friend!”
    • Goal- $15,000
    • Total- $18, 254
    • Top 5 team for the Chicago Light the Night Walk
    • Top 10 team for the entire state of Illinois
    • Events organized-
      • 1st annual Katelyn M Joyce Memorial Golf Outing, over 150 attendees and 50+ sponsors!
      • Wine Tasting Event
      • Online, individual fundraising
  • 2011 & Prior
    • $5141 from individual fundraising

Our goal for 2014 is $25,000! If you are interested in being a part of one of our events, joining our team or anything else contact us today and we will be happy to work with you!

[The info below is from the Leukemia and Lymphoma Society]

Information on LLS and Light the Night Walks

Light The Night Walk is The Leukemia & Lymphoma Society’s annual fundraising walk to pay tribute and bring hope to people battling cancer. Hundreds of thousands of participants raise funds for lifesaving research and patient services.

For more than 60 years, The Leukemia & Lymphoma Society (LLS) has been solely focused on people with blood cancers. Presently, we have more than $250 million committed to research across the United States and in ten other countries. Every dollar is provided by concerned donors. We invest in the best, outcome based science:

  • Anywhere, with no geographic or institutional boundaries
  • Without profit incentive
  • To meet unmet Medicare needs of people with blood cancers

And LLS funded advances are helping patients beyond those for whom they were originally developed, including people with solid tumors and auto-immune diseases. In the past decade, nearly 50% (19 out of 39) of the cancer drugs approved by the FDA were approved as treatments for blood cancer patients. Twelve are already approved for people beyond those for whom they were first developed. With your help, we are saving lives.